Home › Disturbo depressivo maggiore › California › Orange
Studi clinici su Disturbo depressivo maggiore a Orange, CA
13 studi su Disturbo depressivo maggiore cercano partecipanti presso sedi a Orange e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
In reclutamentoFase 3
- NRC Research Institute, Orange
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
In reclutamentoFase 2
- Nrc Research Institute, Orange
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
In reclutamentoFase 3
- ATP Clinical Research, Orange
- NRC Research Institute, Orange
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
In reclutamentoFase 3
- Vanda Investigational Site, Orange
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
In reclutamentoFase 4
- Neurocrine Clinical Site, Orange
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
In reclutamentoFase 2
- PNS Clinical Research LLC dba ATP Clinical Research, Orange
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
In reclutamentoFase 3
- ATP Clinical Research Orange County, Orange
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
In reclutamentoFase 3
- ATP Clinical Research, Orange
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
In reclutamentoFase 3
- Atp Clinical Research, Orange
- Nrc Research Institute, Orange
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
In reclutamentoFase 3
- Neurocrine Clinical Site, Orange
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
In reclutamentoFase 3
- Neurocrine Clinical Site, Orange
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
In reclutamentoFase 2
- Autobahn Site #152, Orange
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
In reclutamentoFase 3
- Neurocrine Clinical Site, Orange
Studi su Disturbo depressivo maggiore in altre città
- New York City, NY37 studi
- Boston, MA31 studi
- Atlanta, GA25 studi
- Philadelphia, PA23 studi
- Orlando, FL19 studi
- Miami, FL18 studi
- Chicago, IL17 studi
- Tampa, FL17 studi
- Houston, TX16 studi
- San Diego, CA16 studi
- Little Rock, AR14 studi
- Austin, TX13 studi
Altri studi a Orange
- Cancro del polmone non a piccole cellule25 studi
- Cancro metastatico20 studi
- Cancro colorettale16 studi
- Cancro ovarico16 studi
- Cancro pancreatico15 studi
- Cancro al seno14 studi
- Cancro ai polmoni14 studi
- Cancro alla prostata14 studi
- Cancro al fegato (carcinoma epatocellulare)14 studi
- Melanoma14 studi
- Leucemia mieloide acuta13 studi
- Cancro (tutti i tipi)13 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.